NorthWest Biotherapeutics Inc (NWBO)

[Umibe5690]

Consider that in mild COVID-19 cases, the virus has not migrated from the upper respiratory system to the lungs. In this case, there would be at most little inflammation in this region and making it anymore susceptible to bacterial pneumonia. However, if the disease has already migrated to the lungs, it could very quickly develop into viral pneumonia. That is very deadly all by itself and vaccination against bacterial pneumonia may be of insignificant effect and benefit.

I don't know whether vaccinating against bacterial pneumonia is part of SOC in cases of diagnosed COVID-19. I don't know whether it is a standard protocol in severe colds and upper respiratory infections even with fever or in non-COVID-19 flu strains. I will have to pose this question to my own doc when I see him next week. But you could be correct. Anything is possible.